Virax Biolabs Group Ltd has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on December 18, 2023 with the ratio of 1-for-10, meaning that for 10 shares of VRAX owned pre-split, shareholders then owned 1 share. The most recent stock split took place on June 26, 2026 on a 1-for-25 basis.
These actions have increased VRAX stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Virax Biolabs Group Ltd's total market capitalization.
For more detailed information of Virax Biolabs Group Ltd's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Virax Biolabs Group Ltd has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when VRAX stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Virax Biolabs Group Ltd's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
